Last reviewed · How we verify
MIDOMAFETAMINE HYDROCHLORIDE
At a glance
| Generic name | MIDOMAFETAMINE HYDROCHLORIDE |
|---|---|
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
- Headache
- Nausea
- Insomnia
- Anxiety
- Fatigue
- Muscle Tightness
- Muscle tightness
- Suicidal ideation
- Dizziness
- Hyperhidrosis
- Suicidal Ideation
- Decreased Appetite
Key clinical trials
- MDMA-Assisted CBT for OCD (MDMA-CBT4OCD Study) (PHASE2)
- Ecstasy to Alleviate SEvere Chronic Neuropathic Pain Trial (PHASE2)
- MDMA Plus Exposure Therapy for PTSD (PHASE2)
- MDMA-Assisted Massed Exposure Therapy for PTSD (PHASE2)
- MDMA-assisted Brief Cognitive Behavioral Conjoint Therapy for PTSD (PHASE3)
- High-Intensity Inpatient MDMA-Assisted Psychotherapy for PTSD (PHASE2)
- Study Comparing Two Versus Three Active MDMA-assisted Sessions in U.S. Military Veterans With Chronic PTSD (PHASE2)
- Group MDMA-therapy for Veterans With PTSD (PHASE1, PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |